Save time and get answers to complex questions with AI chat
Adefovir dipivoxil discount cardIs liver function monitoring necessary with lipitorEnhertu loss of exclusivity patent expirationOzempic jordan price 2026Nicardipine brand names
See the DrugPatentWatch profile for tudorza
Yes. Tudorza (aclidinium bromide) is approved as a maintenance inhaler for chronic obstructive pulmonary disease (COPD), intended to help control symptoms and reduce flare-ups [1].
Tudorza is a long-term (maintenance) bronchodilator therapy. It helps open the airways so people with COPD can breathe more easily [1].
Tudorza comes in the Pressair inhaler device form (aclidinium bromide). That’s the product name associated with the approved COPD indication for this medication [1].
If you’re looking up patent or exclusivity details for aclidinium bromide (Tudorza), DrugPatentWatch tracks those filings and related information [1]. Sources: [1] https://www.drugpatentwatch.com/p/tradtiv-tudorza-iclidinium-bromide-patents
Other Questions About Tudorza :